enVVeno Medical Corporation

NVNO Healthcare Medical Devices

In the quarter to June 2026, EPS grew 53.6% and free cash flow grew 4.60%, each against the same quarter a year earlier.

7.47 0.46 −5.80%
Market cap
$5.5M
P/E
0.0×
Fwd P/E
−0.7×
Dividend yield
—
F-score
3/9
Altman Z
−28.30
Beneish M
n/a
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
— — — —

+8 more quarters

EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
11.70 11.89 13.58 13.12
Net Debt/EBITDA
5.70 6.33 7.24 6.50
Debt/Equity
0.00 0.00 0.00 0.00
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
(5.29) (4.95) (5.85) (7.65)
Book value per Share
30.80 36.31 46.06 51.27
Free Cash Flow
(3.55) (3.24) (3.44) (4.39)
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates